Thus, Wicky and coworkers [206] reported that podoplanin stimulates MCF7 breast cancer cell migration in the absence of EMT, an event linked to downregulation of RhoA, RhoC, and Cdc42 GTPase activities. The gene discussed is PDPN; the disease is breast carcinoma.